Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1038/s41416-022-02075-z
Published Online: 2022-12-07
Published Print: 2023-02-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bodmer, Walter http://orcid.org/0000-0001-6244-9792
Text and Data Mining valid from 2022-12-07
Version of Record valid from 2022-12-07
Article History
Received: 13 October 2022
Revised: 10 November 2022
Accepted: 15 November 2022
First Online: 7 December 2022
Competing interests
: The author declares no competing interests.